SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sharbon Bio (590034)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590034 NSE: Pharmaceuticals & Drugs | Small Cap | Sharon Bio Share Price

BSE Share Price
Not Listed

Sharbon Bio (590034)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590034 NSE: Pharmaceuticals & Drugs | Small Cap | Sharon Bio Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹260 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹16.5
TTM Sales
₹172 Cr.
Book Value per Share
₹44.9
P/E Ratio
15.46
Industry PE
26.5
Price to Book (P/B)
5.68
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
17%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
85.14%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
62.98%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹35 Cr.
Equity
₹10.2 Cr.
Face Value
₹10
All Time Low / High
₹10.50 / 275.00

Sharbon Bio stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'04Mar'05TTM
ROCE % 0%0%-

Growth Parameters

Sales 133246172
Sales YoY Gr.-85.1%-
Adj EPS 8.316.316.5
YoY Gr.-97.8%-
BVPS (₹) 18.150.544.9
Adj Net
Profit
8.320.417
Cash Flow from Ops. -13.912.4-
Debt/CF from Ops. -6.77-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANA85.1%
Adj EPS NANANA97.8%
BVPSNANANA179.5%
Share Price - - - -

Key Financial Parameters

Mar'04Mar'05TTM
Return on
Equity %
18.727.934.6
Op. Profit
Mgn %
19.31715.1
Net Profit
Mgn %
6.28.39.8
Debt to
Equity
31.1-
Working Cap
Days
01540
Cash Conv.
Cycle
0810

Profit And Loss

(All Figures are in Crores.)
data not found
No data found!

Valuation of Sharon Bio - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
data
No data found!

Cash Flow

(All Figures are in Crores.)
data
No data found!

Financial Ratio

data
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sharbon Bio FAQs

The current trading price of Sharon Bio on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sharon Bio stood at ₹259.6 Cr

The latest P/E ratio of Sharon Bio as of 31-Dec-1969 is 15.46.

The latest P/B ratio of Sharon Bio as of 31-Dec-1969 is 5.68.

The 52-week high of Sharon Bio is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sharon Bio is ₹172 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Sharbon Bio

No data to display
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: